CCL2 and obesity disorder: Wy-14,643–a PPARα agonist–increased AdipoR expression and decreased monocyte chemoattractant protein-1 (MCP-1) expression, ameliorating obesity related inflammation in adipose tissue as well as systemic insulin resistance in mice [133].